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Background: The significance of achieving good glycaemic control cannot be over-emphasized as this goes a long way in the reduction of 
disease burden arising from diabetes mellitus. In Nigeria, insulin injections are still widely unacceptable thus posing a problem towards 
achieving optimal glycaemic control in insulin requiring diabetes patients. 
Aim: This study aimed to provide information on insulin usage in Nigeria.
Patients and Methods: The study was carried out in the Lagos State University Teaching Hospital (LASUTH) and the Lagos University 
Teaching Hospital (LUTH), Lagos, Nigeria. Participants were recruited from patients receiving care at the Diabetes Clinic of the above 
mentioned hospitals. It is a descriptive study in which 100 insulin-requiring diabetes patients were studied via the use of interviewer-
administered questionnaire.
Results: Essentially, insulin techniques, glycaemic control and complications of insulin usage were documented.
Conclusions: The main form of insulin used is the human insulin. High cost of insulin is one of the major factors responsible for poor 
glycaemic control. For proper delivery of diabetes care, insulin, insulin pens and syringes must be available, accessible and at affordable 
cost. 
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INTRODUCTION
Diabetes mellitus (DM) is a metabolic disorder that is seen in 
2.2% of Nigerians (1). In Africa, DM is one of the prominent 
causes of mortality of all non-infective, chronic diseases (2). There 
are still a lot of erroneous beliefs concerning DM and its treatment 
amongst Nigerians with the disorder. Insulin usage which is a must 
for those with Type 1 DM and for some people with Type 2 DM is 
often seen as burdensome and even a source of stigma for the user. 
In Nigeria where there is no viable health insurance scheme, 
payment for medical purposes is often “out of pocket”. As a result 
of this, people with DM who require insulin for survival may find 
it difficult to procure the much needed drug thus resulting in 
epileptic self administration of insulin. There is a dearth of 
literature on insulin usage in Nigerians with diabetes. This study 
aims to bridge this gap.
PATIENTS AND METHODS
This study, a descriptive one, was carried out at the Diabetes 
Clinics of the Lagos State University Teaching Hospital 
(LASUTH), Ikeja, and Lagos University Teaching Hospital Lagos 
(LUTH) from January 2003 to December 2004. These are the 
biggest government owned hospitals in the South West of Nigeria. 
These clinics are run once a week and are designed to render care 
to patients with diabetes-referrals and old patients inclusive. The 
total number of patients receiving diabetes care each week in these 
clinics is estimated to be one hundred and twenty.
Data collection was done through the use of questionnaires 
which were interviewer-administered, clinical examination and 
laboratory methods. These questionnaires were administered to 
insulin-requiring patients with DM. Information obtained from the 
questionnaires include the documented demographic 
characteristics, type and duration of DM, type of insulin delivery 
system/devices used insulin injections sites and complications of 
insulin viz, hypoglycaemia and skin changes. The skin changes 
sought out for include lipo-atrophy, lipo-hypertrophy, 
urticaria/rash, hyper-pigmentation and any other skin changes 
noticed at the site of insulin administration.
Metabolic assessment or glycaemic control was determined 
using the fasting plasma glucose (FPG) values.
OPERATIONAL DEFINITIONS
1. Good glycaemic control refers to a weighted means of 
fasting plasma glucose (FPG)  <120mg%.
2. Poor glycaemic control refers to a weighted means of 
fasting plasma glucose (FPG) >121mg%.
3. Obesity is said to be present if the Body Mass Index 
-2is>25kg/m .
4. Type 1 DM refers to people in whom the diagnoses of 
DM was made before the age of 30 years and are on 
insulin for control of DM.
5. Insulin requiring Type 2 DM: These refers to people in 
whom the diagnosis of DM was made after the age of 30 
years and were initially on diet or diet/oral 
hypoglycaemic agents for glycaemic control but later 
placed on insulin therapy on an outpatient basis for 
glycaemic control.  
The test statistics used included unpaired Student’s t test and 
Chi squared test. The student’s t test was used to test for 
differences between quantitative variables. The Chi squared test 
was used to test for associations and comparison of proportions. 
The level of statistical significance was set at pd”0.05.
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RESULTS
A total of 100 insulin-requiring DM patients were seen at the 
out-patient diabetes clinic of LASUTH and LUTH during the 
period of January – December, 2003. The male: female ratio was 
1:1. The mean age standard deviation of the subjects was 45.8(14) 
years, mean standard deviation of the body mass index was 
224.3(4.9) kg/m .  The mean age (SD) of males was 47.1±13.4 
years while that of females was 44.5±14.8 years. The age range of 
the male subjects was 15-70years while that of the female 
subjects was 18-73 years. With a p value of >0.05, these 
differences were not statistically significant. 
The mean (SD) duration of DM was 9.2±7.7 years with a 
range of 1-30 years. The mean (SD) of fasting plasma glucose 
(FPG) was in the poor glycaemic range and this was 170 (77) 
mg% (table 1).
Over half (61%) of these subjects had no formal education 
and were involved in semi-skilled occupations. About 55% of 
these subjects belonged to a low socio-economic class.
Figure 1 shows that 30 (30%) of insulin requiring subjects 
were aged between 48-58 years while those that are  aged 70 years 
and above  are in the age bracket that least require insulin for the 
control of their glycaemia. 
Seventy percent (70%) of insulin requiring subjects with DM 
had type 2 DM and this group had a longer mean duration of DM 
which was statistically significant. 
A vast majority, 86 (86%) of the study subjects used human 
insulin while 14 (14%) were on porcine insulin. The intermediate 
forms of insulin especially the combination of regular and NPH 
insulin was the main form of insulin used. The insulin 
administering devices commonly used by the subjects were the 
insulin syringes. These were used by 82 (82%) of the subjects 
while only 18 (18%) used insulin pens. Eight (44%) of those that 
used insulin pens achieved good glycaemic control while only 16 
(24%) of those that used insulin syringes attained good glycaemic 
control. This difference was statistically significant p<0.05. Of the 
patients studied, 57 (57%) were non-literate, and in this group, 8 
(14%) used insulin pens while 10(23%) of those that were 
educated used the pens. 
About half (51%) of the study subjects admitted to skipping 
their insulin injections. Only 16 (31%) of the subjects in this group 
were able to achieve good glycaemic control. 
Rotating insulin injection sites was practiced by 85 (85%) of 
the study subjects while swabbing of insulin injection sites and 
pinching up of the skin prior to injection was practiced by 84 
(84%) and 77 (77%) of the patients respectively. There was no 
statistically significant difference documented in glucose control 
in those that rotated their injection sites, swabbed and pinched up 
their skin prior to insulin injection. Glucose control was generally 
poor in these groups of people.
A large percentage (72%) of insulin-requiring patients with 
DM did not practice self- home glucose monitoring. Self-home 
glucose monitoring was carried out by 28 (28%) of the subjects 
and of this group, only 8 (28%) used blood glucose meters. The 
others used stix strips and their urine to assess glycaemic control.
Figure 2 shows the insulin injection sites used the most 
frequently used injection site was the thigh while 2 (2%) of the 
subjects used their calf muscles for insulin administration.
The daily frequency of insulin injections is showed in table 2. 
The occurrence of hypoglycaemia was documented in 70 (70%) of 
these insulin- requiring people with diabetes. Hypoglycaemic 
episodes were documented in 80% of people with type 2 DM. 
The skin changes that were noted in this study include 
hyperpigmentation, lipo-atrophy, lipo-hypertrophy and the 
presence of rashes. Hyper pigmentation was the commonest-
occurring skin lesion and this was present in about 37% of the 
study subjects. These details are shown in figure 3.  
Table 1: Clinical features of subjects with types 1 
and 2 diabetes mellitus
Variable Type 1 DM Type 2DM P value
No (M:F) 30(16:14) 70 (34:36) >0. 05
BMI 24.3±4.9 26.8±3.1 >0.05
Age 36.1(6.4) 59.2 (7.3) < 0. 05
Duration of  
DM (years)
Mean (SD) 5.28 (5.99) 10.49 (7.88) <0.05
Glycaemic 
control
Mean (SD) 152 (8) 177 (8) >0.05
Range 80-160 68-185
Table 2: Frequency of insulin injections
Frequency Percentage (%)
 Once daily 12
Twice daily 68
Thrice daily 12
Four times daily 1
Infrequently 7
 













Figure 2: Insulin injection sites
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Figure 3: Skin manifestations of insulin injection
DISCUSSION
The majority of the subjects studied were middle aged with a 
mean age of 46 years. Though the males were older than the 
females; this difference was not statistically significant. The mean 
weight and Body Mass Index of the subjects were within normal 
limits. However, people with type 2 DM were overweight while 
those with type 1 DM had normal BMI. In all, the percentage of 
those people in the low socio-economic bracket was higher-55%- 
than those in the higher economic class. The fact that this study 
was carried out in government hospitals where patient care is 
partly subsidized may account for this socio-educational picture. 
Type 2 DM was the main form of diabetes in the patients’ studied-
accounting for 70% of them. The global distribution of diabetes is 
such that type 2 DM is estimated to account for about 98% of all 
cases of DM (3). Those with type 2 DM were older than those with 
Type 1 DM and this difference was statistically significant p<0.05. 
This is in keeping with the diagnostic criteria of both forms of DM 
(4). 
The mean value of the duration of DM was higher in those 
with Type 2 DM than in those with Type 1 DM. This goes to 
emphasize the fact that people with Type 2 DM may resort to use of 
insulin with progressive waning of beta cell function (5). 
The main form of insulin used is human insulin: this was used 
by 86(86%) of all the subjects studied. For a resource-poor country 
like ours this figure is impressive. It goes to show that there is an 
increasing acceptance of the guidelines of the International 
Diabetes Federation (IDF) which state amongst others that the use 
of human insulin be embraced by all insulin-requiring DM patients 
whilst usage of porcine insulin is discontinued (6). The 
intermediate forms of insulin especially the pre-mixed form of a 
long-acting and short acting insulin- were commonly prescribed 
and used. This insulin came in the form of a mixture of 70% of 
long- acting and 30% of short acting insulin. A small percentage of 
people mixed insulin themselves. In 68% of the subjects studied, 
insulin was administered twice daily. However some of these 
people admitted to under-dosing so as to reduce the cost of insulin 
replacement. Again the irregular administration of insulin by 
insulin- requiring DM subjects is brought to the fore by this study 
in which irregular usage of insulin was documented in 7% of the 
study subjects. Reasons volunteered by such patients ranged from 
financial constraints, unavailability inaccessibility to insulin 
supplies. 
The cost of procuring insulin for those using the syringes 
amounts to about 5,000- 7000 Nigerian Naira monthly while the 
cost for those on insulin pens range from about  10,000-12,500 
Nigerian Naira monthly. This is against the backdrop of a 
minimum monthly wage of 7,500 Nigerian Naira. In Nigeria, there 
are three main pharmaceutical companies that have the franchise 
to distribute insulin and these include Eli-Lilly, Novo Nordisk and 
an indigenous company that imports insulin from India. This is 
only a little cheaper than the ones provided by the two “giant” 
insulin companies and there is no provision of insulin pens yet by 
this indigenous pharmaceutical company.
For proper delivery of diabetes care, insulin, insulin pens, 
insulin syringes and needles should be available, accessible and at 
an affordable cost to all people with diabetes who require them. 
Continuous accessibility to insulin is still a major problem in many 
developing countries especially those in sub-Saharan Africa such 
that there are reports of premature deaths due to the chronic lack of 
7access to insulin in these countries . 
Insulin pens and syringes were the insulin administrative 
devices used by the study subjects. Insulin pumps are yet to be 
made available to the Nigerian market by the producers. Insulin 
syringes which come cheaper were commonly used. Only 18 
(18%) of them used insulin pens. Though the general trend in this 
study was that of poor glycaemic control, in those that used the pen 
devices, a higher percentage of them had good glycaemic control 
than those that used insulin syringes. There was no relationship 
noted between the use of either of the administrative devices and 
socio-economic class. The injection main sites used for insulin 
administration were the thighs, abdomen, abdomen and the deltoid 
muscle. All the subjects injected insulin at the recommended sites 
(8) except for a small percentage of them (2%) who used their calf 
muscles. The site commonly used was the thigh muscles-this was 
observed in 62% of the subjects. Only 7% of these people used the 
abdomen for injections. The technique of insulin administration 
had no bearing on the glycaemic control as portrayed in this study. 
More than 50% of people were poorly-compliant with their insulin 
regimen. The relationship between poor drug compliance and 
glycaemic control is clearly evident as shown in the results 
obtained. This is a notable finding in people who require insulin 
for long-term control of glucose (9).
Self-glucose monitoring, a useful component of patient self 
care practices is not widely practised amongst our patients with 
DM. Financial constraints, ignorance and poverty are definite 
hindrances to this practice. The cost of the glucose measuring 
meter is 7,500 Nigerian Naira. Reasons for this include high cost 
of testing supplies, lack of diabetes education, lack of interest by 
patients and lack of testing supplies.
Hypoglycaemia in diabetes is a reflection of the inadequacies 
of current medical management of diabetes. This study showed 
that at some time, 70 (70%) of the insulin requiring subjects had 
experienced hypoglycaemic episodes. This is not surprising given 
that the pharmacodynamics of conventional insulin therapies do 
not reproduce the physiological circulating insulin levels of 
health, creating risks of severe hypoglycaemia that can be reduced 
but not avoided by rigidity of lifestyle and prescription of frankly 
abnormal eating habits (10). The association of skin changes with 
insulin administration was noted in about 80% of the study 
subjects and hyperpigmentation was the commonest skin change 
noted. 
High costs and lack of motivation are some of the factors most 
likely responsible for the poor glycaemic control noted in this 
study. Educating the diabetes patients, subsidizing insulin costs 
and accessibility to convenient means of injections such as the use 
of the insulin pen and blood glucose-monitoring meters will go a 
long way in motivating the patient toward achieving optimal 
diabetes control.
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